IT8125185A0 - NEW GALENIC FORM OF FENOFIBRATE, HIS PROCESS TO OBTAIN IT, ITS APPLICATION AS A MEDICINAL PRODUCT. - Google Patents

NEW GALENIC FORM OF FENOFIBRATE, HIS PROCESS TO OBTAIN IT, ITS APPLICATION AS A MEDICINAL PRODUCT.

Info

Publication number
IT8125185A0
IT8125185A0 IT8125185A IT2518581A IT8125185A0 IT 8125185 A0 IT8125185 A0 IT 8125185A0 IT 8125185 A IT8125185 A IT 8125185A IT 2518581 A IT2518581 A IT 2518581A IT 8125185 A0 IT8125185 A0 IT 8125185A0
Authority
IT
Italy
Prior art keywords
fenofibrate
application
medicinal product
galenic form
new galenic
Prior art date
Application number
IT8125185A
Other languages
Italian (it)
Other versions
IT1144948B (en
Inventor
Claude Laruelle
Original Assignee
Laruelle Claude Villeneuve Lou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laruelle Claude Villeneuve Lou filed Critical Laruelle Claude Villeneuve Lou
Publication of IT8125185A0 publication Critical patent/IT8125185A0/en
Application granted granted Critical
Publication of IT1144948B publication Critical patent/IT1144948B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT25185/81A 1980-11-19 1981-11-19 NEW GALENIC FORM OF PHENOFIBRATE, ITS PROCESS TO OBTAIN IT, ITS APPLICATION AS A MEDICINAL PRODUCT IT1144948B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024568A FR2494112B1 (en) 1980-11-19 1980-11-19

Publications (2)

Publication Number Publication Date
IT8125185A0 true IT8125185A0 (en) 1981-11-19
IT1144948B IT1144948B (en) 1986-10-29

Family

ID=9248140

Family Applications (1)

Application Number Title Priority Date Filing Date
IT25185/81A IT1144948B (en) 1980-11-19 1981-11-19 NEW GALENIC FORM OF PHENOFIBRATE, ITS PROCESS TO OBTAIN IT, ITS APPLICATION AS A MEDICINAL PRODUCT

Country Status (8)

Country Link
EP (1) EP0065531A1 (en)
AT (1) AT387517B (en)
BE (1) BE891129A (en)
DE (1) DE3152519C2 (en)
FR (1) FR2494112B1 (en)
IT (1) IT1144948B (en)
NL (1) NL8120434A (en)
WO (1) WO1982001649A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
FR2556964A1 (en) * 1983-12-23 1985-06-28 Ile De France NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY
JPS60221078A (en) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd Granular product of useful microorganism powder and its preparation
IT1180507B (en) * 1984-06-29 1987-09-23 Roberto Valducci PROCEDURE FOR THE PREPARATION OF ETOFIBRATE OR SUBSTANCES OF EQUAL OR SIMILAR CHARACTERISTICS, IN MICROGUNULI-DELAY AND PRODUCT OBTAINED WITH SUCH PROCEDURE
FR2602423B1 (en) * 1986-08-08 1989-05-05 Ethypharm Sa PROCESS FOR THE PREPARATION OF A FENOFIBRATE-BASED MEDICINAL PRODUCT, OBTAINED BY THIS PROCESS
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
FR2737121B1 (en) * 1995-07-27 1997-10-03 Cl Pharma NEW GALENIC FORMULATIONS OF FENOFIBRATE AND THEIR APPLICATIONS
DE19608750A1 (en) * 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Process for the production of fenofibrate preparations
FR2758459B1 (en) 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2758461A1 (en) * 1997-01-17 1998-07-24 Pharma Pass PHARMACEUTICAL COMPOSITION HAVING HIGH BIOAVAILABILITY AND PROCESS FOR PREPARING THE SAME
DE19858789A1 (en) 1998-12-18 2000-06-21 Bayer Ag Medicament combination of cerivastatin and fibrate, has additive effect in the treatment of lipid metabolism disorders, e.g. dyslipidemia or atherosclerosis
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6383517B1 (en) 1999-01-29 2002-05-07 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6368622B2 (en) 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6180138B1 (en) 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2795961B1 (en) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (en) 2001-01-22 2004-03-12 Fournier Lab Sa NEW FENOFIBRATE TABLETS
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN1713823A (en) * 2002-11-22 2005-12-28 明治制果株式会社 Granular composition and process for producing the same
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
RU2356549C2 (en) * 2002-12-17 2009-05-27 Эббетт ГмбХ унд Ко.КГ Composition containing phenofibrin acid, its physiologically acceptable salt or derivative
WO2005002541A2 (en) * 2003-07-02 2005-01-13 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
EP1785133A1 (en) 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
FR1347413A (en) * 1963-01-29 1963-12-27 Italnysco S P A Broad-acting spherules or globules and method for their preparation
GB1415295A (en) * 1971-10-14 1975-11-26 Orchimed Sa Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
FR2313915A1 (en) * 1976-01-26 1977-01-07 Corneille Gilbert Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating
LU77353A1 (en) * 1977-05-16 1979-01-19
FR2432313A1 (en) * 1978-08-01 1980-02-29 Foulhoux Pierre Micro:granules contg. beta-histine - for controlled release and less side effects useful in treating Menieres syndrome

Also Published As

Publication number Publication date
IT1144948B (en) 1986-10-29
AT387517B (en) 1989-02-10
ATA906481A (en) 1988-07-15
FR2494112A1 (en) 1982-05-21
DE3152519C2 (en) 1990-11-22
BE891129A (en) 1982-05-17
FR2494112B1 (en) 1986-01-10
EP0065531A1 (en) 1982-12-01
DE3152519T1 (en) 1983-12-29
NL8120434A (en) 1982-10-01
WO1982001649A1 (en) 1982-05-27

Similar Documents

Publication Publication Date Title
IT8125185A0 (en) NEW GALENIC FORM OF FENOFIBRATE, HIS PROCESS TO OBTAIN IT, ITS APPLICATION AS A MEDICINAL PRODUCT.
IT8125451A0 (en) THERAPEUTIC COMPOSITION TO OVERCOME SNORING.
DE3583930D1 (en) CLEANING OF SOLUTIONS TO THE BAYER PROCESS.
ES529257A0 (en) PROCESS TO REDUCE THE STICK OF A HEAT-ADHESIVE ADHESIVE IN THE FORM OF TABLETS.
FI873630A0 (en) STABILT PHARMACEUTICAL PRODUCT.
DK222282A (en) FRACTURED DISTILLATION PROCESS
BR7903644A (en) DISPOSABLE PRODUCT
DE3483722D1 (en) NEW INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF MEDICINAL PRODUCTS.
IT1094039B (en) PROCESS FOR THE PREPARATION OF 2,2,6,6-TETRAMETHY-4-PIPERIDONE
BE874135A (en) NEW PROSTACYCLINE ANALOGUES, THEIR PRODUCTION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
IT7822323A0 (en) PROCESS FOR THE SYNTHESIS OF ALKYLENCARBONATES.
IT8124601A0 (en) NEW GALENIC FORM OF ADMINISTRATION OF METHOCLOPRAMIDE, ITS MANUFACTURING PROCESS AND DRUG INCLUDING THIS NEW FORM.
IT1154559B (en) PRODUCT TO INTERRUPT THE DORMITURE OF SPROUTS
IT1219447B (en) PIPERRAZINCARBOSSILIC ACID, ITS PREPARATION AND ITS USE AS A MEDICATION
IT1148289B (en) PRODUCT TO CRUSH, AS WELL AS DEVICE FOR ITS PREPARATION
IT7828258A0 (en) PROCESS FOR THE PRODUCTION OF LACTULOSE.
MX156574A (en) CATALYTIC IMPROVED PROCESS TO OBTAIN THE TERTIARY BUTILESTIRENE
IT7927636A0 (en) PROCESS TO OBTAIN AROMATIC CARBONATES BY SYNTHESIS.
IT1207017B (en) METHYL-NONYL-ACETALDEHYDE PRODUCTION PROCESS
IT1099507B (en) EXTRACTIVE PROCESS FOR THE PREPARATION OF APIGENINA
DE3781045D1 (en) ANTIRHEUMATIC MEDICINAL PRODUCT.
IT1115151B (en) PECE PRODUCTION PROCESS
IT7826941A0 (en) 2-PYRIDIL-1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PRODUCTION AS WELL AS THEIR USE AS MEDICINES.
IT7828580A0 (en) DRIVE WHEEL FOR CYCLE COUNTERS.
SE7809345L (en) WAY TO PRODUCE 2,5-DIKETOGLUCONIC ACID